[1]
SARANNYA RAVI, LIYA ROSLIN JOSEPH and SREELAKSHMI VENUGOPAL 2024. COST ANALYSIS OF BRANDED VERSUS GENERIC ANTI-DIABETIC DRUGS USED FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN A TERTIARY CARE HOSPITAL. Asian Journal of Pharmaceutical and Clinical Research. 17, 9 (Sep. 2024), 78–81. DOI:https://doi.org/10.22159/ajpcr.2024v17i9.51620.